Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 801–900 of 1,009
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine
Contreras, A. V., Cocom-Chan, B., Hernández‐Montes, G., Portillo-Bobadilla, T., & Reséndis-Antonio, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00606 · Cited by 51
Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
Wainwright, P., Scorletti, E., & Byrne, C. D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0851-x · Cited by 52
Obesity linking to hepatocellular carcinoma: A global view
Gan, L., Liu, Z., & Sun, C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.006 · Cited by 51
Shima, K. R., Ota, T., Kato, K., Takeshita, Y., Misu, H., Kaneko, S., & Takamura, T. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000469 · Cited by 49
Tsuji, H., Matsuda, K., & Nomoto, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01417 · Cited by 57
Bacterial biofilm in colorectal cancer: What is the real mechanism of action?
Mirzaei, R., Mirzaei, H., Alikhani, M. Y., Sholeh, M., Arabestani, M. R., Saidijam, M., Karampoor, S., Ahmadyousefi, Y., Moghadam, M. S., Irajian, G. R., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104052 · Cited by 49
Chen, C., Yang, R., & Xu, H. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01803-1 · Cited by 49
Droujinine, I. A., & Perrimon, N. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00082 · Cited by 51
Guo, Q., Liang, S., Xiao, Z., & Ge, C. (2022) · Food Reviews International · doi:10.1080/87559129.2022.2039182 · Cited by 46
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 53
MAFLD: an optimal framework for understanding liver cancer phenotypes
Crane, H., Gofton, C., Sharma, A., & George, J. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02021-7 · Cited by 51
Rivera‐Esteban, J., Muñoz, S., Higuera, M., Sena, E., Bermúdez-Ramos, M., Bañares, J., Martínez-Gómez, M., Cusidó, M. S., Jiménez-Masip, A., Francque, S., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.028 · Cited by 52
Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer
Gou, H., Zeng, R., Lau, H. C.-H., & Yu, J. Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107373 · Cited by 50
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 54
From fructans to difructose dianhydrides
Wang, X., Yu, S., Zhang, T., Jiang, B., & Mu, W. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6238-x · Cited by 46
Ji, Y., Sun, S., Goodrich, J. K., Kim, H., Poole, A. C., Duhamel, G. E., Ley, R. E., & Qi, L. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.040 · Cited by 45
The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know
Doycheva, I., Leise, M. D., & Watt, K. D. S. (2015) · Transplantation · doi:10.1097/tp.0000000000001008 · Cited by 47
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Exploring the microbiota to better understand gastrointestinal cancers physiology
Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46
Yoshitsugu, R., Kikuchi, K., Iwaya, H., Fujii, N., Hori, S., Lee, D. G., & Ishizuka, S. (2019) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.65.45 · Cited by 51
Obesity and hepatocellular carcinoma: Hype and reality
El‐Serag, H. B., & Kanwal, F. (2014) · Hepatology · doi:10.1002/hep.27172 · Cited by 45
Prevention of Metabolic Syndrome by Phytochemicals and Vitamin D
Santa, K., Kumazawa, Y., & Nagaoka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032627 · Cited by 50
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 81
Kuliš, E., Cvitković, I., Pavlović, N., Kumrić, M., Rušić, D., & Božić, J. (2025) · Antibiotics · doi:10.3390/antibiotics14080828 · Cited by 52
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
Ferrín, G., de la Mata, M., Montero-Álvarez, J. L., Aguilar‐Melero, P., & Rodríguez‐Perálvarez, M. (2015) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s50161 · Cited by 44
Dong, T. S., Chang, H.-H., Hauer, M., Lagishetty, V., Katzka, W. R., Rozengurt, E., Jacobs, J. P., & Eibl, G. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00170.2019 · Cited by 48
The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation
Zhang, K., Zhang, M., Luo, Z., Wen, Z., & Yan, X. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.09.005 · Cited by 46
Li, J., Li, J., Ni, J., Zhang, C., Jia, J., Wu, G., Sun, H., & Wang, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.752512 · Cited by 50
The Role of Bile Acids in the Human Body and in the Development of Diseases
Shulpekova, Y. O., Жаркова, М. С., Tkachenko, P. E., Тихонов, И. Н., Stepanov, A. A., Sinitsyna, A. A., Izotov, A., Butkova, T. V., Shulpekova, N. V., Лапина, Н. В., et al. (2022) · Molecules · doi:10.3390/molecules27113401 · Cited by 49
Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer
Zhao, J., & Lawless, M. W. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.009 · Cited by 47
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“The released DCA can induce SASP of HSCs and aggravate liver cell tumorigenesis [143].”
BackgroundNonalcoholic Steatohepatitis Drug Development Pipeline: An Update
Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 51
Ming, K., Zhuang, S., Ma, N., Nan, S., Li, Q., Ding, M., & Ding, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1033875 · Cited by 46
Non-alcoholic fatty liver disease-related hepatocellular carcinoma
Daher, D., Dahan, K. S. E., & Singal, A. G. (2023) · Journal of Liver Cancer · doi:10.17998/jlc.2022.12.30 · Cited by 48
Zou, Y., Li, C., Fu, Y., JiZe, X.-P., Zhao, Y., Peng, X., Wang, J., Yin, Z., Li, Y., Song, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124689 · Cited by 49
Comparative profiling of serum, urine, and feces bile acids in humans, rats, and mice
Zheng, D., Ge, K., Qu, C., Sun, T., Wang, J., Jia, W. P., & Zhao, A. (2024) · Communications Biology · doi:10.1038/s42003-024-06321-3 · Cited by 56
Shen, T. D., Pyrsopoulos, N., & Rustgi, V. K. (2018) · Liver Transplantation · doi:10.1002/lt.25008 · Cited by 50
Naito, Y., Higashimura, Y., Baba, Y., Inoüe, R., Takagi, T., Uchiyama, K., Mizushima, K., Hirai, Y., Ushiroda, C., & Tanaka, Y. (2018) · Medical Gas Research · doi:10.4103/2045-9912.229597 · Cited by 50
The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
M�ndez-S�nchez, N., Valencia-Rodríguez, A., Vera-Barajas, A., Abenavoli, L., Scarpellini, E., & Rodríguez, G. P. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.29 · Cited by 46
Chen, T., Ding, R., Chen, X., Lu, Y., Shi, J. H., Lü, Y., Tang, B., Zhang, W., Ye, C., Yuan, M., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1982273 · Cited by 49
Caviglia, J. M., & Schwabe, R. F. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_8 · Cited by 46
Rotge, J. ‐., Poitou, C., Fossati, P., Aron‐Wisnewsky, J., & Oppert, J. ‐. (2017) · Obesity Reviews · doi:10.1111/obr.12549 · Cited by 42
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 48
Qiu, Y., Xu, J., Liao, W., Wen, Y., Jiang, S., Wen, J., & Zhao, C. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.04.008 · Cited by 46
Zhou, Y., Jia, Y., Xu, N., Tang, L., & Chang, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126172 · Cited by 46
Rad, H. F., Tahmasebi, H., Javani, S., Hemati, M., Zakerhamidi, D., Hosseini, M., Alibabaei, F., Banihashemian, S. Z., Oksenych, V., & Eslami, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122776 · Cited by 46
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 47
Kao, E., Yang, M., Hung, C.-H., Huang, C., & Wang, C. (2015) · Food & Function · doi:10.1039/c5fo00714c · Cited by 52
Response of Intestinal Bacterial Flora to the Long-term Feeding of Aflatoxin B1 (AFB1) in Mice
Yang, X., Liu, L., Chen, J., & Xiao, A. (2017) · Toxins · doi:10.3390/toxins9100317 · Cited by 49
Harris, S. C., Devendran, S., Alves, J. M. P., Mythen, S. M., Hylemon, P. B., & Ridlon, J. M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.12.001 · Cited by 44
Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress
Tadokoro, Y., Hoshii, T., Yamazaki, S., Eto, K., Ema, H., Kobayashi, M., Ueno, M., Ohta, K., Arai, Y., Hara, E., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.04.002 · Cited by 42
Self-citationZhou, L., Yang, F., Li, G., Huang, J., Liu, Y., Zhang, Q., Tang, Q., Hu, C., & Zhang, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00517 · Cited by 42
Antimicrobial proteins: intestinal guards to protect against liver disease
Hendrikx, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1521-8 · Cited by 44
A Multi-Omics Study of Chicken Infected by Nephropathogenic Infectious Bronchitis Virus
Xu, P., Liu, P., Zhou, C., Shi, Y., Wu, Q., Yang, Y., Li, G., Hu, G., & Guo, X. (2019) · Viruses · doi:10.3390/v11111070 · Cited by 46
Ikejima, K., Kon, K., & Yamashina, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0202 · Cited by 43
The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
Ni, Y., Lu, M., Xu, Y., Wang, Q., Gu, X., Li, Y., Zhuang, T., Xia, C., Zhang, T., Gou, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.908011 · Cited by 48
Miller, K. N., Li, B., Pierce-Hoffman, H. R., Patel, S., Lei, X., Rajesh, A., Teneche, M. G., Havas, A. P., Gandhi, A., Macip, C. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57229-3 · Cited by 229
Luo, X., Wang, K., & Jiang, C. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.020 · Cited by 45
Microbiota and nonalcoholic steatohepatitis
Imajo, K., Yoneda, M., Ogawa, Y., Wada, K., & Nakajima, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0404-6 · Cited by 45
Ito, M., & Adachi‐Akahane, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r09cp · Cited by 43
Wu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8641 · Cited by 46
Singh, A. K., Brito, I., & Lammerding, J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.01.008 · Cited by 49
Intestinal barrier regulates immune responses in the liver via IL-10–producing macrophages
Taniki, N., Nakamoto, N., Chu, P., Mikami, Y., Amiya, T., Teratani, T., Suzuki, T., Tsukimi, T., Fukuda, S., Yamaguchi, A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.91980 · Cited by 45
Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer
Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 45
Li, Z., Zhang, L., Gao, M., Han, M., Liu, K., Zhang, Z., Gong, Z., Xing, L., Shi, X., Lu, K., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1012-z · Cited by 41
RetractedThe gut microbiome and frailty
Piggott, D. A., & Tuddenham, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.012 · Cited by 46
Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
Li, Z., Zhang, C., Du, J., Zhao, J., Shi, M., Jin, M., & Liu, H. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01269-w · Cited by 44
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis
Wang, X., Zeldin, S., Shi, H., Zhu, C., Saito, Y., Corey, K. E., Osganian, S. A., Remotti, H. E., Verna, E. C., Pajvani, U. B., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.031 · Cited by 42
Lee, Y.-T., Liu, C., Hu, Y., Teng, C., Tzeng, C., Yeh, C., Chen, T., Lin, J.-K., Lin, C., Lan, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000001079 · Cited by 46
Trust Your Gut: The Association of Gut Microbiota and Liver Disease
Manzoor, R., Ahmed, W., Afify, N., Memon, M., Yasin, M., Memon, H., Rustom, M., Akeel, M. A., & Alhajri, N. (2022) · Microorganisms · doi:10.3390/microorganisms10051045 · Cited by 46
The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD
Cheng, Z., Yang, L., & Chu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.002 · Cited by 46
Dysbiosis and extraintestinal cancers
He, R., Qi, P., Shu, L.-Z., Ding, Y., Zeng, P., Wen, G., Xiong, Y., & Deng, H. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03313-x · Cited by 49
Aging-associated oxidative stress inhibits liver progenitor cell activation in mice
Cheng, Y., Wang, X., Wang, B., Zhou, H., Dang, S., Shi, Y., Li, H., Luo, Q., Jin, M., Zhou, Q., et al. (2017) · Aging · doi:10.18632/aging.101232 · Cited by 42
Takakura, K., Oikawa, T., Nakano, M., Saeki, C., Torisu, Y., Kajihara, M., & Saruta, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00762 · Cited by 40
Sojoodi, M., Wei, L., Erstad, D. J., Yamada, S., Fujii, T., Hirschfield, H., Kim, R. S., Lauwers, G. Y., Lanuti, M. D., Hoshida, Y., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0383 · Cited by 43
Intestinal microbial metabolite stercobilin involvement in the chronic inflammation of ob/ob mice
Sanada, S., Suzuki, T., Nagata, A., Hashidume, T., Yoshikawa, Y., & Miyoshi, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-63627-y · Cited by 42
Human Gut Microbiome and Liver Diseases: From Correlation to Causation
Li, R., Mao, Z., Ye, X., & Zuo, T. (2021) · Microorganisms · doi:10.3390/microorganisms9051017 · Cited by 42
Filho, R. I., Ochioni, A. C., Esteves, A. M., Leandro, J. G. B., Demaria, T. M., Sola‐Penna, M., & Zancan, P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03929-9 · Cited by 41
Microbiome metabolite quantification methods enabling insights into human health and disease
Laro, J. A., Mital, R., Haffner, J. J., Colwell, N., Coats, R., Palacios, H. M., Liu, Z., Godinho, J. L. P., Ness, M., Peramuna, T., et al. (2024) · Methods · doi:10.1016/j.ymeth.2023.12.007 · Cited by 42
Hypothalamic inflammation and the central nervous system control of energy homeostasis
Pimentel, G. D., Ganeshan, K., & Carvalheira, J. B. C. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.005 · Cited by 47
Steatosis and Steatohepatitis: Complex Disorders
Bettermann, K., Hohensee, T., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069924 · Cited by 48
The influence of the commensal microbiota on distal tumor-promoting inflammation
Rosean, C. M. B., & Rutkowski, M. R. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.06.002 · Cited by 41
Miragem, A. A., & de Bittencourt, P. I. H. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx020 · Cited by 41
Cheng, Z., Lin, J., Gao, N., Sun, X., Meng, X., Liu, R., Liu, Y., Wang, W., Li, B., & Wang, Y. (2020) · Food Science and Human Wellness · doi:10.1016/j.fshw.2020.04.006 · Cited by 40
Examining the gut-liver axis in liver cancer using organoid models
Shek, D., Chen, D., Read, S. A., & Ahlenstiel, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.008 · Cited by 40
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development
Bellotti, R., Speth, C., Adolph, T. E., Lass‐Flörl, C., Effenberger, M., Öfner, D., & Maglione, M. (2021) · Cancers · doi:10.3390/cancers13143431 · Cited by 41
Lu, Y., Yuan, H., Liang, S., Li, D., Jiang, P., Wang, X., Zhang, K., & Liu, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603658 · Cited by 45
Mikuriya, Y., Tashiro, H., Kuroda, S., Nambu, J., Kobayashi, T., Amano, H., Tanaka, Y., & Ohdan, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29096 · Cited by 39
Nicholson, S. E., Burmeister, D. M., Johnson, T. R., Zou, Y., Lai, Z., Sayyadioskoie, S., DeRosa, M., Jonas, R. B., Merrill, D. R., Zhu, C. S., et al. (2019) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002201 · Cited by 38
Ezzaidi, N., Zhang, X., Coker, O. O., & Yu, J. Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114425 · Cited by 40
Elsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 39
The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
Weinberg, F. D., Dickson, R. P., Nagrath, D., & Ramnath, N. (2020) · Cancers · doi:10.3390/cancers13010013 · Cited by 42
Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases
Liu, J., Yang, D., Wang, X., Asare, P. T., Zhang, Q., Na, L., & Shao, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.774335 · Cited by 45
Dietary fat and lipid metabolism in the tumor microenvironment
Goswami, S., Zhang, Q., Celik, C. E., Reich, E. M., & Yilmaz, Ö. H. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188984 · Cited by 41
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
Wei, M., Tu, W., & Huang, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1341938 · Cited by 46
Saha, B., Rithi, A. T., Adhikary, S., Banerjee, A., Radhakrishnan, A., Duttaroy, A. K., & Pathak, S. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2367266 · Cited by 41
Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis
Pang, X., Tang, Y.-J., Ren, X., Chen, Q., Tang, Y., & Liang, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01353 · Cited by 39
Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria
Aindelis, G., & Chlichlia, K. (2020) · Vaccines · doi:10.3390/vaccines8020329 · Cited by 43
Carlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.